1. Home
  2. ZLAB vs SENEB Comparison

ZLAB vs SENEB Comparison

Compare ZLAB & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SENEB
  • Stock Information
  • Founded
  • ZLAB 2013
  • SENEB 1949
  • Country
  • ZLAB China
  • SENEB United States
  • Employees
  • ZLAB N/A
  • SENEB N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SENEB Packaged Foods
  • Sector
  • ZLAB Health Care
  • SENEB Consumer Staples
  • Exchange
  • ZLAB Nasdaq
  • SENEB Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SENEB 720.7M
  • IPO Year
  • ZLAB 2017
  • SENEB N/A
  • Fundamental
  • Price
  • ZLAB $35.19
  • SENEB $101.56
  • Analyst Decision
  • ZLAB Buy
  • SENEB
  • Analyst Count
  • ZLAB 5
  • SENEB 0
  • Target Price
  • ZLAB $54.28
  • SENEB N/A
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • SENEB 579.0
  • Earning Date
  • ZLAB 08-07-2025
  • SENEB 08-07-2025
  • Dividend Yield
  • ZLAB N/A
  • SENEB N/A
  • EPS Growth
  • ZLAB N/A
  • SENEB N/A
  • EPS
  • ZLAB N/A
  • SENEB 5.90
  • Revenue
  • ZLAB $418,326,000.00
  • SENEB $1,578,887,000.00
  • Revenue This Year
  • ZLAB $44.07
  • SENEB N/A
  • Revenue Next Year
  • ZLAB $49.13
  • SENEB N/A
  • P/E Ratio
  • ZLAB N/A
  • SENEB $17.21
  • Revenue Growth
  • ZLAB 43.72
  • SENEB 8.25
  • 52 Week Low
  • ZLAB $16.01
  • SENEB $57.51
  • 52 Week High
  • ZLAB $44.34
  • SENEB $107.99
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • SENEB 61.20
  • Support Level
  • ZLAB $32.31
  • SENEB $101.00
  • Resistance Level
  • ZLAB $35.72
  • SENEB $94.02
  • Average True Range (ATR)
  • ZLAB 1.10
  • SENEB 0.45
  • MACD
  • ZLAB -0.34
  • SENEB -0.02
  • Stochastic Oscillator
  • ZLAB 60.17
  • SENEB 57.67

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SENEB Seneca Foods Corp. Class B

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

Share on Social Networks: